IL-17–Producing Vγ4 + γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions
|
journal
|
July 2015 |
The Distribution of Inflammatory Demyelinated Lesions in the Central Nervous System of Rats with Antibody-Augmented Demyelinating Experimental Allergic Encephalomyelitis
|
journal
|
October 1994 |
Role of Sphingosine 1-Phosphate (S1P) Receptor 1 in Experimental Autoimmune Encephalomyelitis —II
|
journal
|
January 2013 |
An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28
|
journal
|
October 2011 |
Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands
|
journal
|
December 2010 |
Fingolimod for Multiple Sclerosis
|
journal
|
January 2012 |
A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation
|
journal
|
September 2012 |
Pathological mechanisms in progressive multiple sclerosis
|
journal
|
February 2015 |
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS): EAE as model for MS
|
journal
|
October 2011 |
Multiple sclerosis—a quiet revolution
|
journal
|
February 2015 |
Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker
|
journal
|
February 2010 |
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
|
journal
|
September 1996 |
Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
|
journal
|
October 2009 |
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
|
journal
|
December 2010 |
Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [ N - 11 C-Methyl]-(−)-Cocaine PET Studies in Human Subjects
|
journal
|
September 1990 |
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond
|
journal
|
August 2013 |
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
|
journal
|
April 1999 |
Role of Sphingosine 1-Phosphate (S1P) Receptor 1 in Experimental Autoimmune Encephalomyelitis —I
|
journal
|
January 2013 |
Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis
|
journal
|
November 2004 |
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
|
journal
|
June 2010 |
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
|
journal
|
October 2010 |
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714
|
journal
|
April 2012 |
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner
|
journal
|
August 2012 |
An update on the biology of sphingosine 1-phosphate receptors
|
journal
|
January 2014 |
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
|
journal
|
September 2007 |
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
|
journal
|
February 2010 |
A promising carbon-11-labeled sphingosine-1-phosphate receptor 1-specific PET tracer for imaging vascular injury
|
journal
|
February 2016 |
Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules
|
journal
|
March 2009 |
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation
|
journal
|
September 2013 |
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
|
journal
|
May 2007 |
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography
|
journal
|
October 2014 |
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
|
journal
|
January 2010 |
Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2)
|
journal
|
October 2000 |
BZM055, an Iodinated Radiotracer Candidate for PET and SPECT Imaging of Myelin and FTY720 Brain Distribution
|
journal
|
January 2011 |
S1P 1 Receptor Modulation with Cyclical Recovery from Lymphopenia Ameliorates Mouse Model of Multiple Sclerosis
|
journal
|
October 2011 |
Fingolimod phosphate promotes the neuroprotective effects of microglia
|
journal
|
March 2013 |
Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis
|
journal
|
March 2011 |
Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography
|
journal
|
April 2015 |
PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model
|
journal
|
June 2014 |
Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions: SIP Receptor 1 and 3 are Upregulated in MS Lesions
|
journal
|
May 2010 |